Label-free microfluidic paper-based electrochemical aptasensor for ultrasensitive and simultaneous multiplexed detection of cancer biomarkers by Wang, Yang et al.
  
 
 
 
 
Wang, Y., Luo, J., Liu, J., Sun, S., Xiong, Y., Ma, Y., Yan, S., Yang, Y., Yin, H. and 
Cai, X. (2019) Label-free microfluidic paper-based electrochemical aptasensor for 
ultrasensitive and simultaneous multiplexed detection of cancer biomarkers. Biosensors 
and Bioelectronics, 136, pp. 84-90. 
 
   
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
http://eprints.gla.ac.uk/186544/  
      
 
 
 
 
 
 
Deposited on: 25 October 2019 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk  
  
 1 
Label-free microfluidic paper-based electrochemical aptasensor for 
ultrasensitive and simultaneous multiplexed detection of cancer 
biomarkers 
Yang Wang
a,b
, Jinping Luo
a,b
, Juntao Liu
a,b
, Shuai Sun
a,b
, Ying Xiong
c
, YuanYuan Ma
c
, Shi Yan
c
, 
Yue Yang
c
, Huabing Yin
d
, Xinxia Cai
a,b*
 
a State Key Laboratory of Transducer Technology, Institute of Electronics, Chinese Academy of Sciences, Beijing 100190, 
China. 
b University of Chinese Academy of Sciences, Beijing 10090, China 
c Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Surgery II, 
Peking University Cancer Hospital & Institute, Beijing 100142, China  
d Division of Biomedical Engineering, School of Engineering, University of Glasgow, Oakfield Avenue, Glasgow 
G12 8LT, United Kingdom 
*
Corresponding Email: xxcai@mail.ie.ac.cn Tel: +86 10 58887193 
Abstract 
Simultaneous detection of multiple tumor biomarkers in body fluids could facilitate early diagnosis of 
lung cancer, so as to provide scientific reference for clinical treatment. This paper depicted a 
multi-parameter paper-based electrochemical aptasensor for simultaneous detection of carcinoembryonic 
antigen (CEA) and neuron-specific enolase (NSE) in a clinical sample with high sensitivity and specificity. 
The paper-based device was fabricated through wax printing and screen-printing, which enabled functions 
of sample filtration and sample auto injection. Amino functional graphene (NG)-Thionin (THI)- gold 
nanoparticles (AuNPs) and Prussian blue (PB)- poly (3,4- ethylenedioxythiophene) (PEDOT)- AuNPs 
nanocomposites were synthesized respectively. They were used to modify the working electrodes not only 
for promoting the electron transfer rate, but also for immobilization of the CEA and NSE aptamers. A 
label-free electrochemical method was adopted, enabling a rapid simple point-of-care testing. 
Experimental results showed that the proposed multi-parameter aptasensor exhibited good linearity in 
ranges of 0.01 ~ 500 ng mL
-1
 for CEA (R
2
=0.989) and 0.05 ~ 500 ng mL
-1
 for NSE (R
2
=0.944), 
respectively. The limit of detection (LOD) was 2 pg mL
-1
 for CEA and 10 pg mL
-1
 for NSE. In addition, 
the device was evaluated using clinical serum samples and received a good correlation with large 
electrochemical luminescence (ECL) equipment, which would offer a new platform for early cancer 
diagnostics, especially in those resource-limit areas. 
Keywords: Electrochemical Aptasensor; Microfluidic Paper-based Device; Nanocomposites; Multiplexed 
Detection; Cancer Biomarkers 
 
1. Introduction 
With the increasingly worsening air pollution over the past decades, lung cancer has been one of the 
most threatening cancer to people’s health and life worldwide (Lin et al. 2017; Song et al. 2016). The 
rapid simultaneous detection of multiple cancer biomarkers in body fluids could help confirm lung cancer 
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as soon as possible, so as to provide scientific reference for clinical treatment (Xu et al. 2017). However, 
the determination of a single tumor marker usually has a limiting clinical reference value (Gao et al. 2017; 
Lu et al. 2015). Thus, simultaneous detection of two or more biomarkers, with high sensitivity and 
specificity, has gained lots of attention recently (Jia et al. 2014).  
To date, immunoassay is one of the most widely accepted methods for detection of trace cancer 
biomarkers due to that antibody has high affinity towards the corresponding antigen (Zhang et al. 2008); 
(Mazzu-Nascimento et al. 2017). Various immunoassay technologies have been developed based on 
antibody-antigen interaction, including but not limited to radioimmunoassay (RIA) (Bast Jr et al. 1983), 
chemiluminescence immunoassay (CLIA) (Ge et al. 2012; Zong et al. 2012), fluorescence immunoassay 
(FIA) (Wacker and Niemeyer 2004), electrochemiluminescence (ECL) (Babamiri et al. 2018), 
enzyme-linked immunosorbent assay (ELISA) (Gordon and Cross 1990) and electrochemical 
immunoassay (EIA) (Lai et al. 2009; Tsai et al. 2016). Of all these above-mentioned methods, the 
label-free electrochemical method, for its outstanding advantages of high selectivity and sensitivity, has 
been recognized as a powerful tool for multiplexed detection of cancer biomarkers (Sun and Ma 2013; 
Wei et al. 2018). In addition, it eliminates the need for labelling, making the detection a point-of-care 
testing. Some works based on electrochemical detection of single tumor marker have been reported before. 
For example, Lv et al. proposed a sandwich-type electrochemical immunosensor using AuNPs 
functionalized polydopamine (PDA) as transducing materials for detection of CEA, with a limit of 
detection of 0.167 pg mL
-1
 (Lv et al. 2018). Zhang et al. reported an electrochemical immunosensor, 
which employed reduced graphene oxide-thionin-hemin-Au (H-rGO-THI-Au) nanohybrid as probe, for 
highly sensitive measurement of NSE (Zhang et al. 2018).   
However, compared to antibodies, nucleic acid aptamers have lower immunogenicity, higher affinity, 
wider receptor range and better selectivity, and thus have found increasing applications in scientific and 
industrial communities since its discovery (Hermann and Patel 2000) (Famulok et al. 2000); (Song et al. 
2008). The aptamers are generally selected by a mature technology called Systematic Evolution of 
Ligands by Exponential Enrichment (SELEX) (Fang and Tan 2009), making them rather cost effective 
and chemically stable (Sefah et al. 2010). What’s more, they offer remarkable flexibility for the structural 
design and easy modification of functional groups on their 5’ end (Gubala et al. 2011). Thus, aptamers 
have become increasingly important molecular tools in the field of diagnostics and therapeutics, leading 
to a range of aptamer receptors based bioassays (Maehashi et al. 2007; Zhou et al. 2014). In addition, not 
only the performance of the aptasensors has been significantly improved via the use of novel 
nanomaterials, but also the continuous development of nanotechnology offers a new horizon for 
aptamer-based detections (Sanghavi et al. 2015); (Wu et al. 2014).  
Microfluidic paper-based device (μPAD), as an alternative platform for point-of-care testing, has 
gained tremendous attention since it was first reported by Whiteside’s group (Martinez et al. 2007). After 
that, Henry’s group has successfully introduced the electrochemical methods onto a paper device for the 
detection of glucose, lactate and uric acid by oxidase-based enzymatic reactions (Dungchai et al. 2009). In 
our previous work, a microfluidic paper-based electrochemical immunosensor modified with graphene 
nanocomposites was fabricated for highly sensitive and fast detection of CEA (Wang et al. 2016). Once 
the microfluidic channels were fabricated on μPAD, the flow direction of the liquid could be controlled, 
thus enabling simultaneous detection of multiple targets in a single biological sample. With so many 
attractive properties, such as low-cost, easy-to-use and portable, μPAD has become a promising and ideal 
analytical platform, especially in those less developed countries (Zhao et al. 2013); (Martinez et al. 2009).  
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In this paper, a paper-based device was fabricated for simultaneous multiplexed detection of CEA and 
NSE. The device could enable detection of two cancer biomarkers in a single biological sample. 
NG-THI-AuNPs and PEDOT-PB-AuNPs nanocomposites were synthesized and modified directionally 
onto the surface of the corresponding working electrodes, which could not only facilitate electron transfer 
capability but also increase the amount of immobilized aptamers, thus significantly enhancing the 
sensitivity of the electrochemical aptasensor. Adopting a label-free electrochemical detection method, the 
device could be used for point-of-care testing. This newly developed paper-based aptasensor, with high 
sensitivity, high selectivity and affordable diagnostic test device, would offer a new platform for early 
cancer diagnostic, especially in those resource-limit areas. 
2. Experimental 
2.1. Apparatus 
Electrochemical measurements were performed with a Bio-Logic VMP3 multi-channel potentiostat 
(BIO-LOGIC, France). A three electrode system was used during measurement and all potentials given in 
this work were referred to the screen-printed Ag∣AgCl electrode. To fabricate the microfluidic channels, 
a Xerox ColorQube 8570 digital wax printer was used to spray wax on the surface of paper, followed with 
baking in a Yiheng oven (DHG-9023A, Yiheng, China). Transmission electron microscopy (TEM) images 
of the nanocomposites were characterized on a Hitachi H7650 (HITACHI, Japan) transmission electron 
microscope. 
2.2. Materials 
DNA aptamer against CEA: 5’-ATA CCA GCT TAT TCA ATT-3’ (Mw 5628.83 g mol
-1
) and DNA 
aptamer against NSE: 5’-CGG TAA TAC GGT TAT CCA CAG AAT CAG GGG-3’ (Mw 9476.29 g mol
-1
) 
were synthesized and purified by Sangon Biotechnology Co. Ltd. (Shanghai, China). The two aptamers 
were modified with thiol groups on their 5’ end in order to bond with AuNPs. CEA and NSE antigens, 
Tris- Ethylenediaminetetraacetic acid (EDTA) buffer solution (10mM Tris-HCl + 1mM EDTA, pH=8.0) 
were also obtained from Sangon Biotechnology Co. Ltd. FeCl3·6H2O, K3[Fe(CN)6] and HCl were 
purchased from Beijing Chemical Reagents Co. Ltd. (Beijing, China). Whatman NO. 1 chromatography 
paper was purchased from GE Healthcare Worldwide (Shanghai, China). The conductive carbon ink for 
working electrode and counter electrode was bought from Acheson, and Ag|AgCl ink (CNC-01) was from 
Yingman Nanotechnology Company. Other reagents, including thionine acetate was purchased from Alfa 
Aesar, 3,4-ethylenedioxythiophene (EDOT) and 6-mercaptohexanol (MCH) from Sigma-Aldrich and NG 
from Xianfeng Nanomaterials Company. All reagents were of analytical grade and used without further 
purification. Clinical serum samples were provided by Peking University Cancer Hospital & Institute.    
2.3. Fabrication of Paper microfluidics  
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Scheme.1 Fabrication and modification process of the multi-parameter electrochemical paper-based aptasensor: (1) sample 
inlet hole; (2) filter hole; (3) screen-printed counter electrode; (4) screen-printed reference electrode; (5) detection zone; (6) 
screen-printed working electrode. 
Scheme.1 illustrates the paper-based aptasensor for multiplexed detection. The device can detect two 
analytes in one sample simultaneously as two working electrodes were integrated onto a single device. 
The device was fabricated on four pieces of cropped cellulose filter papers, and thus had the filtering 
function. For the operation of the device, a sample was introduced from the sample inlet located on the 
side, flowed through the microchannel, and reached the location where the three-electrode system was 
screen printed. Multiplexing analysis of the device was realized since the capillary action guided the 
sample to the two independent working electrodes on the paper within hot wax printed channels, and then 
recognized by the corresponding DNA aptamers (Wang et al. 2018). The device combined low cost and 
ease of use with the sensitivity of electrochemical detection.  
Without the need of any specialized facilities or a clean room, the device was fabricated through four 
steps. The first step is to design the structures using Adobe Illustrator CS5. The size of the device was 
designed to be 10.5 mm × 35.0 mm. The counter electrode and the reference electrode were grouped 
together in one layer to form a circle, while the working electrode was located directly below. 
Registration marks were designed on each layer to ensure the assembling accuracy.  
A filter paper was then printed with hot wax using a Xerox digital wax printer according to the 
designed pattern, followed by heating at 120 ℃ for 5 minutes in an oven to melt the printed wax. 
Because of the porous structure of the paper, the wax would diffuse through it to form the same 
hydrophobic pattern on both sides. Subsequently, three electrodes were screen printed on the 
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corresponding site, where the working electrode and the counter electrode were of conductive carbon ink, 
while the reference electrode was of Ag|AgCl ink. Finally the papers were integrated together using a 
double side tape into the device.  
2.4. Synthesis of NG-THI-AuNPs nanocomposites  
The process of synthesizing NG-THI-AuNPs nanocomposites was as follows: a total of 2 mg NG 
was mixed with 2 mL ultrapure water in a round bottom flask, followed by 30 min ultrasonic process to 
form a stable NG solution. After that, 2 mL of THI solution (2 mg mL
-1
) was added to the above flask and 
then stirred vigorously for 24 hours. THI molecules would non-covalently attach to the surface of NG due 
to the π-π stacking interactions between benzene rings. Remove the non-integrated THI molecules by 
centrifugation and washing several times to obtain the NG-THI nanocomposites. The as-synthesized 
nanocomposites were then dispersed in 2 mL water. Then 10 mL AuNPs solution, whose diameter was 
about 15 nm, was added to the above dispersion and stirred overnight to promote the AuNPs fully 
integration with the amino groups of NG. The AuNPs were prepared according to a literature (Guo and 
Wang 2007). Finally, after washing and centrifugation, NG-THI-AuNPs nanocomposites were obtained 
and stored at 4 °C for further use.  
2.5. Synthesis of PB-PEDOT-AuNPs nanocomposites  
PB-PEDOT nanocomposites were synthesized by the oxidative polymerization of EDOT in the 
presence of Fe
3+ 
ions (Yang et al. 2017). The specific reactions could be described as follows:  
Fe
3+
 + EDOT → Fe2+ + PEDOT                                             (1) 
Fe
2+
 + [Fe(CN)6]
3-
 → Fe3[Fe(CN)6]2 (PB)                                      (2) 
The two reactions above occurred in the same time in a typical synthesis. The PB-PEDOT 
nanocomposites were of core-shell structure, which could significantly improve the stability and 
conductivity of PB. Briefly, 50 μL EDOT was first dissolved in 5 mL of ethanol solution and then 
transferred to 25 mL of 0.1 M HCl to form a stable solution. Meanwhile, 13.2 mg K3[Fe(CN)6] and 10.8 
mg FeCl3·6H2O were added to 10 mL of 0.1M HCl solution and then sonicated for 30 min. The obtained 
two solutions were mixed together under vigorously stirring. As the reaction proceeded, the color of the 
mixture turned into dark blue gradually, indicating the formation of PB-PEDOT nanocomposites. After 
centrifugation and washing, the mixture was dried in an oven. Eventually, 10 mL of AuNPs solution was 
added to 2 mL PB-PEDOT suspension (1 mg mL
-1
) and stirred overnight to form PB-PEDOT-AuNPs 
nanocomposites.  
2.6. Fabrication of the multiplexed paper-based aptasensor  
The schematic diagram of the stepwise modification process of the multiplexed paper-based 
aptasensor was also shown in Scheme.1. For the fabrication, 10 μL NG-THI-AuNPs and 10 μL 
PB-PEDOT-AuNPs nanocomposites were coated on the corresponding surface of working electrode of 
the microfluidic paper device, separately. Put the modified device at 50 °C in an oven for half an hour. 
Then 10 μL of CEA aptamers was dropped onto the surface of NG-THI-AuNPs modified electrode while 
another 10 μL of NSE aptamers was introduced onto the PB-PEDOT-AuNPs modified electrode, followed 
with washing with 1 mL of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 7.4) to remove the unbound 
aptamers. The concentrations of CEA and NSE aptamers were optimized at 28 μg mL
-1
 and 47 μg mL
-1
, 
respectively. As the aptamers had already been modified with thiol groups on their 5’ end, which 
facilitated their conjugation with AuNPs through Au-S bond. Next, 10 μL of 1mM MCH solutions were 
employed to block any nonspecific binding sites. After 1 hour of incubation at room temperature, the 
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modified paper aptasensor was washed with 1 mL of TE buffer three times. The prepared aptasensor was 
stored at 4 °C for further use. Each time before electrochemical measurement, 20 μL biological samples, 
such as standard solutions and clinical serum samples, containing certain concentration of CEA and NSE 
antigens were added to the device from the sample inlet hole and incubated for 1 hour.  
2.7. Electrochemical measurements of CEA and NSE  
The basic electrochemical properties of the developed paper-based aptasensor were mainly 
characterized by cyclic voltammetry (CV) while the response to the CEA and NSE antigens were 
conducted by the differential pulse voltammetry (DPV). All electrochemical experiments were carried out 
in a VMP3 multi-channel potentiostat in PBS solution (pH = 7.4). The DPV curves were recorded in the 
range of -0.5 V to 0.3 V, with 5 mV step potential, 0.025 s modulation time and 0.5 s interval time. 
Besides, CV was conducted at a scan rate of 100 mV s
-1 
between -0.5 V to 0.3 V. Two sets of conventional 
three-electrode system were integrated into a single paper device.   
3. Results and discussions 
3.1. Characterization of NG-THI-AuNPs and PB-PEDOT-AuNPs nanocomposites  
 
Fig.1 TEM images of the synthesized nanocomposites. (A) TEM image of NG-THI-AuNPs nanocomposites; (B) TEM 
image of PB-PEDOT-AuNPs nanocomposites. 
NG-THI-AuNPs and PB-PEDOT-AuNPs nanocomposites were synthesized to immobilize CEA and 
NSE aptamers, separately. TEM images (Fig. 1A-B) illustrated the morphology of the synthesized two 
nanocomposites. NG showed wrinkled paper-like structure (Fig. 1A), which could provide a large surface 
area to load the electrochemical-active thionin molecules through π-π stacking interactions. AuNPs, with 
a size of approximately 15 nm, were clearly observed on the surface of graphene. They were immobilized 
because of the interactions between gold and amino groups. The synthesized PB-PEDOT-AuNPs showed 
a 3D hierarchical porous structure (Fig. 1B), which could significantly improve the stability of the PB 
molecules. Their unique structure and large surface area, could promote the electron transfer rate, thus 
enhancing the current signal. In addition, the AuNPs were distributed uniformly within the matrix, which 
facilitated not only the electron transfer, but also immobilization of the thiol modified aptamers of CEA 
and NSE through Au-S bond.  
3.2. Electrochemical Characterization of the paper-based aptasensor   
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Fig.2 Electrochemical properties of the paper-based aptasensor monitored in 0.1 M PBS solution (pH=7.4). (A) CV responses 
of the NG-THI-AuNPs modified working electrode for CEA detection: (a1) NG-THI-AuNPs nanocomposites modified 
electrode; (a2) NG-THI-AuNPs/CEA aptamer modified electrode; (a3) bare working electrode; (B) CV responses of the 
PB-PEDOT-AuNPs modified working electrode for NSE detection: (b1) PB-PEDOT-AuNPs nanocomposites modified 
electrode; (b2) PB-PEDOT-AuNPs/NSE aptamer modified electrode; (b3) bare working electrode; (C) DPV responses of the 
multi-parameter paper-based aptasensor towards CEA and NSE: (c1) NG-THI-AuNPs nanocomposites modified electrode; 
(c2) NG-THI-AuNPs/CEA aptamer modified electrode; (c3) the multi-parameter aptasensor incubated with 100 pg mL-1 of 
CEA; (c4) bare working electrode; (c5) PB-PEDOT-AuNPs nanocomposites modified electrode; (c6) 
PB-PEDOT-AuNPs/NSE aptamer modified electrode; (c7) the multi-parameter aptasensor incubated with 100 pg mL-1 of 
NSE. 
Electrochemical detection methods, including CV and DPV, were used to characterize basic 
properties of the paper-based electrochemical aptasensor after successful modification with 
NG-THI-AuNPs and PB-PEDOT-AuNPs nanocomposites. Fig.2A and Fig.2B showed the result of CV 
scan, which could be used to investigate the properties of electrode surface. Compared with bare working 
electrode, well behaved electrochemical responses which exhibited two pronounced redox peaks were 
obtained due to the electroactivity of THI and PB molecules (Jia et al. 2014; Sun et al. 2013). The redox 
couple at -0.19/-0.31 V was observed due to the electroactivity of THI molecules while the redox couple at 
+0.04/-0.07 V was due to PB molecules (Yu et al. 2013; Yang et al. 2017). As shown in Fig.2A and Fig.2B, 
the presence of two similar peaks, i.e. cathodic and anodic, was consistent with a typical reversible 
electrochemical behavior. In addition, the electrochemical performance of step-wise immobilization 
procedure of the aptasensor was also monitored in 0.1M PBS solutions. The current intensity decreased 
gradually when corresponding antigens were added onto the surface of the electrode, which was attributed 
to the fact that the formation of aptamer-antigen complex would inhibit the electron transfer process. 
Furthermore, with a higher concentration of antigen, more immunocomplex would form, thus resulting in 
a lower current intensity.  
DPV responses of the aptasensor were shown in Fig.2C. DPV is a well-established technique to 
measure the strength of electrical activity with a much higher sensitivity. Compared with bare working 
electrode (the blue line), the modified electrode showed two pronounced redox peaks at -0.22 V (the 
black line) and 0.01 V (the red line), and whose peak current was 18.02 μA and 14.06 μA, respectively. 
Subsequently, the peak current decreased then the corresponding electrode was immobilized with aptamer 
and antigen. The result of DPV measurements was highly consistent with the principle of our detection 
method. From the results above, we could conclude that the proposed multiplexed electrochemical 
aptasensor was successfully modified and could be used for simultaneous determination of CEA and NSE 
in a single sample. 
3.3. Optimization of the size of AuNPs for the response of aptasensor    
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AuNPs have attracted a lot of attention due to their excellent conductivity and fascinating properties. 
They have been extensively used to develop a variety of highly sensitive biosensors, especially 
electrochemical biosensors. In this work, the AuNPs could not only promote electron transfer between the 
immobilized electroactive materials and the electrode surfaces, but also provide an ideal 
microenvironment for immobilization of CEA and NSE aptamers through the interaction between Au and 
the –SH modified on the 5’ end of the aptamers. Thus, it is crucial to choose an optimal size of AuNPs. 
Different sizes of AuNPs (5 nm, 10 nm, 15 nm, 25 nm, 50 nm, 100 nm) were prepared and used to modify 
the aptasensor. As shown in Fig.S2A, the current response of DPV reached maximum at 15 nm. What’s 
more, TEM images of the synthesized AuNPs were observed to further investigate the size. As shown in 
Fig.S2B, the diameters of the AuNPs were about 15nm. As a result, AuNPs of 15 nm were used in the 
following experiments.  
3.4. Simultaneous Multiplexed Detection of CEA and NSE by the aptasensor  
 
Fig.3 Assay results of simultaneous multiplexed detection of CEA and NSE in 0.1M PBS solution (pH=7.4). (A) DPV 
responses to different concentrations of CEA antigens; (B) The calibration curve between the peak current and logarithm 
concentration of CEA; (C) DPV responses to different concentrations of NSE antigens; (D) The calibration curve between 
the peak current and logarithm concentration of NSE. 
Under optimal conditions, the sensitivity and dynamic range of the multiplexed detection aptasensor 
for CEA and NSE were tested by measuring the change in peak currents of DPV responses. Each 
aptasensor was incubated with a single biological sample which contained certain concentrations of CEA 
and NSE before measurement. The detection of the two analytes was based on the degree of decreased 
peak currents of DPV responses, which was attributed to the formation of aptamer-antigen complex on 
the surface of the electrode. As shown in Fig.3, with the increasing of CEA (Fig.3A) and NSE (Fig.3C), 
the currents decreased gradually. The calibration plots displayed a good linear detection relationship 
between the peak currents and the concentration of analytes in the ranges of 0.01 ~ 500 ng mL
-1
 for CEA 
(R
2
=0.989) and 0.05 ~ 500 ng mL
-1
 for NSE (R
2
=0.944), respectively. In addition, the regression equation 
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obtained between the peak currents of DPV and logarithm concentration of analytes was Idpv (μA) = 
18.495 − 2.796 lg CCEA (ng mL
-1
) for CEA and Idpv (μA) = 11.092 − 1.444 lg CNSE (ng mL
-1
) for NSE, 
separately. The limit of detection (LOD), calculated by the 3σ/S where σ is the standard deviation of the 
lowest signal and S is the slope of linear calibration plot, was 2 pg mL
-1
 for CEA and 10 pg mL
-1
 for NSE, 
respectively.  
Many studies for quantitative detection of CEA and NSE were based on various methods and 
different platforms. The comparison between the proposed aptasensor and some typical biosensors were 
shown in Table.S1. The result illustrated that our paper-based aptasensor had a relatively wide linear 
range and a reasonable low detection limit. What’s more, typically in clinical practice, a level of 5 ng 
mL
-1 
for CEA and 15 ng mL
-1
 for NSE in human serum sample are considered as the cut-off value for 
potential diagnosis of lung cancer. Thus, the multiplexed detection paper-based aptasensor fabricated in 
this work could provide an alternative platform for the early diagnosis of lung cancer. 
3.5. Repeatability, Stability and Selectivity of the paper-based aptasensor  
 
Fig.4 Evaluation of basic properties of the proposed multi-parameter paper-based aptasensor. (A) Comparison of DPV 
response of the aptasensor to 1 ng mL-1 CEA and 1 ng mL-1 CEA mixed with 10 ng mL-1 NSE, BSA, UA, AA, Cyfra21-1, 
separately; (B) Comparison of DPV response of the aptasensor to 1 ng mL-1 NSE and 1 ng mL-1 NSE mixed with 10 ng 
mL-1 CEA, BSA, UA, AA, Cyfra21-1, separately; Repeatability results of (C) NG-THI-AuNPs/CEA aptamer modified 
electrode and (D) PB-PEDOT-AuNPs/NSE aptamer modified electrode; (E) Long-term storage stability of the former 
 10 
proposed paper-based immunosensor to 1 ng mL-1 CEA; (F) Long-term storage stability of the aptasensor to 1 ng mL-1 
CEA. 
The selectivity and specificity of biosensors are of crucial importance for its clinical application with 
clinical serum samples. To characterize the specificity, 1 ng mL
-1
 of CEA and NSE was separately mixed 
with 10 ng mL
-1
 of some potential interference, including Bovine Serum Albumin (BSA), Uric Acid (UA), 
Ascorbic Acid (AA) and Cyfra21-1. As shown in Fig.4A and Fig.4B, although the added concentration of 
interference were 10 times higher than that of target CEA or NSE molecules, the variation in current was 
less than 6.22%. What’s more, the selectivity of the proposed aptasensor was also studied through the 
comparison of the peak currents of 1 ng mL
-1
 CEA or NSE with 1 ng mL
-1 
of above-mentioned 
interference. All results indicated that the proposed multi-parameter had good specificity for both CEA 
and NSE.  
For the low-cost disposable paper-based aptasensor, repeatability is an important parameter. Each 
fabricated paper-based device contained two pairs of electrochemical cell (working electrode, counter 
electrode and reference electrode). To evaluate the repeatability of the multiplexed detection aptasensor, 
four different modified devices were scanned in 0.1M PBS solution by electrochemical workstation. As 
shown in Fig.4C and Fig.4D, the coefficient of variation was 0.56% for NG-THI-AuNPs-CEA aptamer 
modified electrode and 1.22% for PB-PEDOT-AuNPs-NSE aptamer modified one, indicating a good 
repeatability for the multiplexed detection.  
Besides, the stability of the prepared aptasensor was evaluated by keeping the device at 4 °C and 
then scanned the electrode per week. As shown in Fig.4E and Fig.4F, the DPV response of the aptasensor 
to 1 ng mL
-1
 CEA could remain 96.5% of their origin response after four weeks of storage, while the 
paper-based immunosensor we fabricated before could only remain 80.7% of the response (Wang et al. 
2016). The immunosensor was modified with NH2-G/THI/AuNPs nanocomposites and adopted CEA 
antibody as the specific recognition element. As we know, the aptamers were selected and synthesized 
artificially, which were more stable and could be even stored at room temperature for a long time. Thus, 
with the same nanomaterials and a more stable recognition element, the responses of the new sensor to 
CEA were more stable. The results indicated that the sensor had the potential for long-term use.  
3.6. Clinical validation with serum samples  
To further validate the clinical application of our aptasensor, fifteen clinical serum samples provided 
by the Peking University Cancer Hospital were tested. All samples, which contained both CEA and NSE, 
had already been tested in the central lab of the hospital using a commercial-available Roche 
electrochemiluminescence apparatus. The clinical serum samples were detected directly with our sensor 
without any dilution and the analytical results were compared with the reference values provided by the 
hospital. As shown in Table.1, the relative errors between these two methodologies are less than 7.81% 
for CEA and 22.43% for NSE, indicating a good accuracy and high sensitivity for simultaneously 
detection of CEA and NSE in clinical serum samples.  
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Table.1 Assay results of simultaneous detection of CEA and NSE in a same clinical serum sample. 
4. Conclusion 
In this work, a multi-parameter electrochemical paper-based aptasensor was designed and fabricated 
for the simultaneous detection of CEA and NSE in one clinical sample. The microfluidic channels of the 
paper device was fabricated by wax printing while the three-electrode system (working electrode, counter 
electrode and reference electrode) was made by screen printing. Nano composites were synthesized to 
modify the electrodes not only for the immobilization of CEA and NSE aptamers, but also for the signal 
amplification. Under optimal conditions, the multi-parameter aptasensor exhibited good linearity in 
ranges of 0.01 ~ 500 ng mL
-1
 for CEA (R
2
=0.989) and 0.05 ~ 500 ng mL
-1
 for NSE (R
2
=0.944), 
respectively. The limit of detection (LOD) calculated by the 3σ/S was 2 pg mL
-1
 for CEA and 10 pg mL
-1
 
for NSE, respectively. In summary, there are three key benefits of the proposed multi-parameter 
aptasensor: (1) the aptasensor contained two working electrodes, which could enable simultaneous 
detection of two tumor markers in a single sample with high sensitivity and selectivity, so as to provide 
scientific guidance reference for clinical treatment; (2) the aptasensor had a fast response time as a 
label-free electrochemical detection method, which provides a powerful tool for the point-of-care testing 
of cancer biomarkers; (3) the aptasensor was made on paper by wax printing and screen-printing, which 
could be mass-produced easily with low cost. In addition, the cost of a paper device was calculated 
roughly and the total expense was about $ 0.12. This would greatly expand its application to those less 
developed countries. As a result, the proposed aptasensor could provide an optional low-cost and portable 
diagnostics platform for the cancer biomarkers.   
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Figure Captions 
Scheme.1 Fabrication and modification process of the multi-parameter electrochemical paper-based 
aptasensor: (1) sample inlet hole; (2) filter hole; (3) screen-printed counter electrode; (4) screen-printed 
reference electrode; (5) detection zone; (6) screen-printed working electrode.   
 
Fig.1 TEM images of the synthesized nanocomposites. (A) TEM image of NG-THI-AuNPs nanocomposites; 
(B) TEM image of PB-PEDOT-AuNPs nanocomposites.  
 
Fig.2 Electrochemical properties of the paper-based aptasensor monitored in 0.1 M PBS solution (pH=7.4). (A) 
CV responses of the NG-THI-AuNPs modified working electrode for CEA detection: (a1) NG-THI-AuNPs 
nanocomposites modified electrode; (a2) NG-THI-AuNPs/CEA aptamer modified electrode; (a3) bare working 
electrode; (B) CV responses of the PB-PEDOT-AuNPs modified working electrode for NSE detection: (b1) 
PB-PEDOT-AuNPs nanocomposites modified electrode; (b2) PB-PEDOT-AuNPs/NSE aptamer modified 
electrode; (b3) bare working electrode; (C) DPV responses of the multi-parameter paper-based aptasensor 
towards CEA and NSE: (c1) NG-THI-AuNPs nanocomposites modified electrode; (c2) NG-THI-AuNPs/CEA 
aptamer modified electrode; (c3) the multi-parameter aptasensor incubated with 100 pg mL
-1
 of CEA; (c4) 
bare working electrode; (c5) PB-PEDOT-AuNPs nanocomposites modified electrode; (c6) 
PB-PEDOT-AuNPs/NSE aptamer modified electrode; (c7) the multi-parameter aptasensor incubated with 100 
pg mL
-1
 of NSE. 
 
Fig.3 Assay results of simultaneous multiplexed detection of CEA and NSE in 0.1M PBS solution (pH=7.4). 
(A) DPV responses to different concentrations of CEA antigens; (B) The calibration curve between the peak 
current and logarithm concentration of CEA; (C) DPV responses to different concentrations of NSE antigens; 
(D) The calibration curve between the peak current and logarithm concentration of NSE.  
 
Fig.4 Evaluation of basic properties of the proposed multi-parameter paper-based aptasensor. (A) Comparison 
of DPV response of the aptasensor to 1 ng mL
-1
 CEA and 1 ng mL
-1
 CEA mixed with 10 ng mL
-1
 NSE, BSA, 
UA, AA, Cyfra21-1, separately; (B) Comparison of DPV response of the aptasensor to 1 ng mL
-1
 NSE and 1 
ng mL
-1
 NSE mixed with 10 ng mL
-1
 CEA, BSA, UA, AA, Cyfra21-1, separately; Repeatability results of (C) 
NG-THI-AuNPs/CEA aptamer modified electrode and (D) PB-PEDOT-AuNPs/NSE aptamer modified 
electrode; (E) Long-term storage stability of the former proposed paper-based immunosensor to 1 ng mL
-1
 
CEA; (F) Long-term storage stability of the aptasensor to 1 ng mL
-1
 CEA. 
 
Table.1 Assay results of simultaneous detection of CEA and NSE in a same clinical serum sample. 
 
 
 
 
